Peter Albertsen. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Androgen Antagonists/therapeutic useBiopsyDisease-Free SurvivalHumansMaleNeoplasm StagingPatient SelectionPredictive Value of TestsProstate-Specific Antigen/bloodProstatectomyProstatic Neoplasms/diagnosisProstatic Neoplasms/immunologyProstatic Neoplasms/therapyQuality of LifeRisk AssessmentRisk FactorsTime FactorsTreatment OutcomeWatchful Waiting
Substances: See more » Androgen AntagonistsProstate-Specific Antigen
Year: 2010 PMID: 20851512 DOI: 10.1016/j.eururo.2010.09.003
Source DB: PubMed Journal: Eur Urol ISSN: 0302-2838 Impact factor: 20.096